A patient is described with a disturbance of platelet function comparable to that in Glanzmann's thrombasthenia. Platelet aggregation and binding of fibrinogen to the patient's platelets were defective and thrombin-induced clot retraction was absent. The platelet fibrinogen content was only moderately reduced. As measured by monoclonal antibody binding in the presence of divalent cations, the platelets contained about 15% of the normal amount of GPIIb and GPIIIa and only 6% of the normal amount of intact GPIIb/IIIa complex. The residual GPIIb/IIIa complex exhibited a decreased stability as shown by the lack of binding of a complex-dependent anti-GPIIb/IIIa antibody to platelets incubated with ethylene diamine tetraacetic acid (EDTA) at 22 degrees C. Crossed immunoelectrophoresis (CIE) in the presence of divalent cations showed partial dissociation of GPIIb/IIIa as well as the presence of two forms of the residual intact GPIIb/IIIa complex. In addition, both CIE in the presence of the EDTA and two-dimensional sodium dodecyl sulphate (SDS) gel electrophoresis showed the presence of two forms of GPIIb. This form of thrombasthenia is characterized by a defective platelet function, a marked reduction of GPIIb and GPIIIa, decreased stability of the residual GPIIb/IIIa complex and structural heterogeneity of GPIIb.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/j.1365-2141.1989.tb00290.x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
[Regulation of Reactive Oxygen Species on Platelet Activation and Apoptosis].
Zhongguo Shi Yan Xue Ye Xue Za Zhi
October 2024
Suzhou Medical College of Soochow University, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, State Key Laboratory of Radiation Medicine and Protection, Collaborative Innovation Center of Hematology, Suzhou 215006, Jiangsu Province, China.E-mail:
Objective: To investigate how reactive oxygen species (ROS) regulates the signal transduction of platelet activation and apoptosis, and to explore the relationship between platelet activation and apoptosis.
Methods: Platelets were directly stimulated with thrombin or pretreated with ROS inhibitor N-acetylcysteine (NAC) before being stimulated with thrombin, and then flow cytometry was used to detect the effects of thrombin and NAC on P-selectin expression, αⅡbβ3 activation, mitochondrial membrane potential depolarization, phosphatidylserine (PS) externalization, ROS expression and platelet aggregation.
Results: Thrombin could induce the production of ROS in platelets in a concentration- and time-dependent manner.
Platelet Function, Platelet Size and Content of Reticulated Platelets: Interactions in Patients Receiving Dual Antiplatelet Therapy.
Cells
October 2024
Chazov National Medical Research Center of Cardiology, Russian Ministry of Health, 15a, Academician Chazov Str., Moscow 121552, Russia.
Increased platelet activity is a risk factor of thrombotic events in cardiovascular patients. We studied the relationship between platelet function, platelet size, and the content of reticulated platelets (RP) in patients with coronary heart disease (CHD, n = 55) and acute coronary syndrome (ACS, n = 95) receiving acetylsalicylic acid + clopidogrel or ticagrelor, respectively. The control group consisted of patients with risk factors for CHD, but with no CHD/ACS and free of antiplatelet drugs (n = 66).
View Article and Find Full Text PDFMolecular dynamics simulations involving different β-propeller mutations reported in Swiss and French patients correlate with their disease phenotypes.
Sci Rep
October 2024
Gene Therapy Laboratory, Department of Integrative Biology, School of Bio Sciences and Technology, Vellore Institute of Technology, Vellore, 632 014, India.
Integrin αIIbβ3 is the predominant receptor for fibrinogen which mediates platelet aggregation, an important step in hemostasis and thrombosis. Several mutations have been reported in the genes encoding αIIb and β3 subunits among patients with Glanzmann thrombasthenia, of which 177 are in the β-propeller domain. The two subunits form a heterodimer at the interface between β-propeller and β-I domains of αIIb and β3, respectively with their stability critical for intracellular trafficking, surface expression, and ligand binding.
View Article and Find Full Text PDFPlatelet integrin αIIbβ3 plays a key role in a venous thrombogenesis mouse model.
Nat Commun
October 2024
Division of Nephrology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Article Synopsis
- Venous thrombosis (VT) is a serious vascular condition that can lead to decreased survival rates and frequent recurrences, primarily initiated by platelet and neutrophil accumulation at activated endothelial sites.
- The study highlights a new drug, m-tirofiban, which does not activate the platelet receptor αIIbβ3, unlike its predecessor tirofiban, thus avoiding the risk of increased bleeding while effectively suppressing VT in mouse models.
- These results suggest that m-tirofiban and similar compounds could be promising candidates for preventing VT in patients at high risk, balancing efficacy with safety.
USP15-Mediated Deubiquitination of FKBP 5 and Activation of the αIIbβ3 Signaling Pathway Regulate Thrombosis in Mice.
Front Biosci (Landmark Ed)
September 2024
Department of Cardiothoracic Surgery, Changzhou No.2 People's Hospital, The Affiliated Hospital of Nanjing Medical University, 213000 Changzhou, Jiangsu, China.
Article Synopsis
- After treating human platelets with thrombin, it was found that higher levels of USP15 and FKBP5 were expressed; manipulating USP15 levels affected FKBP5 stability and function.
- In experiments with mice lacking USP15 in their platelets, it was shown that this knockdown led to longer bleeding times and reduced thrombus formation, highlighting USP15's important role in regulating blood clotting.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!